Prevalence of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis and Spatial Association With Quarries in a Region of Northeastern France: A Capture–Recapture and Geospatial Analysis
Stéphane Giorgiutti(Inserm), Laurent Arnaud(Inserm), Benoît Nespola(Hôpitaux Universitaires de Strasbourg), Dan Lipsker(Hôpitaux Universitaires de Strasbourg), Julien Campagne, Emmanuel Andrès(Hôpitaux Universitaires de Strasbourg), Yves Dimitrov(Rathenau Instituut), Marie‐Caroline Dalmas(Hôpitaux Universitaires de Strasbourg), Aurélien Guffroy(Inserm), Christian Debry(Hôpitaux Universitaires de Strasbourg), Yannick Dieudonné, Pierre‐Edouard Gavand, O. Imhoff(Centre Hospitalier Sainte-Anne), Yves Hansmann(Hôpitaux Universitaires de Strasbourg), François Mathiaux(Hopitaux Civils de Colmar), O. Hinschberger(Centre Hospitalier de Mulhouse), Jean‐Christophe Weber(Hôpitaux Universitaires de Strasbourg), Anne‐Sophie Korganow(Inserm), François Chantrel(Groupe Hospitalier de la Région de Mulhouse et Sud Alsace), Hanta Nirina Rakotoarivelo(Hopitaux Civils de Colmar), F. de Blay(Hôpitaux Universitaires de Strasbourg), Thierry Martin(Western Infirmary), Alexandre Klein(Hopitaux Civils de Colmar), Vincent Poindron(Inserm), Jacques‐Eric Gottenberg(Hôpitaux Universitaires de Strasbourg), Bruno Moulin, C. Lohmann(Groupe Hospitalier de la Région de Mulhouse et Sud Alsace), Thierry Hannedouche
Cited by 16
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Optimization of Initial Tacrolimus Dose Using Pharmacogenetic Testing
|Clinical Pharmacology & Therapeutics|2010|363